Article info

Download PDFPDF

Letter
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

Authors

  1. Correspondence to Professor Giovanni Targher, Department of Medicine, Endocrinology and Metabolism, University of Verona, Verona 37126, Italy; giovanni.targher{at}univr.it; Professor Ming-Hua Zheng, MAFLD Research Center, Department of Hepatology, The First Affiliated Hospital of Wenzhou Medical University, No 2 Fuxue Lane, Wenzhou 325000, China; zhengmh{at}wmu.edu.cn
View Full Text

Citation

Targher G, Mantovani A, Byrne CD, et al
Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores

Publication history

  • Received April 28, 2020
  • Revised May 4, 2020
  • Accepted May 6, 2020
  • First published May 15, 2020.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.